RxDoctor Payments Data

Lauren Gibson, DPM

Foot & Ankle Surgery · Lafayette, LANPI 1881263085

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot & ankle surgery clinicians in LA, where the typical reported total is $2,260.

$1,502in general payments, 2019–2025

Across 37 payments — averaging $40.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$342
  • Stryker$282
  • Paratek Pharmaceuticals, Inc.$218
  • Organogenesis Inc.$186
  • Medline Industries LP$124
  • Treace Medical Concepts, Inc.$98
  • plus $252 from 7 others

What the payments were for

  • Food & beverage$1,502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,502 in reported general payments places this provider in the 45th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$126,490
Medicare patients
379
Services billed
3,971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin187$7,173
Gabapentin524$5,020
Duloxetine Hcl293$4,590
Daptomycin16$3,366
Vancomycin Hcl17$2,085
Celecoxib84$1,977
Ciclopirox49$1,467
Ammonium Lactate104$1,217
Betamethasone Dipropionate17$600
Diclofenac Sodium30$560
Methylprednisolone78$433
Nitroglycerin PatchNitroglycerin18$363
Mupirocin32$309
Sodium Chloride0.9 % Sodium Chloride27$293
Meloxicam63$189

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →